Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis.
Anti-colon antibody and lymphocytophilic antibody in ulcerative colitis.
复制标题
溃疡性结肠炎的抗结肠抗体和淋巴细胞抗体。
DOI:
--
复制
发表时间:
1982
影响因子:
4.6
通讯作者:
M. Tsuchiya
中科院分区:
文献类型:
--
作者:
T. Hibi;S. Aiso;T. Yoshida;M. Watanabe;H. Asakura;S. Tsuru;M. Tsuchiya
The presence of anti-colon antibody in the sera from patients with ulcerative colitis was demonstrated by antibody-dependent cell-mediated cytotoxicity (ADCC) assay. In addition, the high prevalence of lymphocytophilic antibody in the sera from patients with ulcerative colitis was obtained by fluorescence activated cell sorter (FACS) analysis. This lymphocytophilic antibody was absorbed by rat colon epithelial cells. Moreover the lymphocytes from ulcerative colitis showed lower binding capacity to this antibody, but acquired higher binding capacity after 20 hr incubation at 37 degrees C in vitro. These data suggest that ADCC may have some role in the pathogenesis of ulcerative colitis.